![Atilla Sevinçli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 41 M $ au 30/06/2026
Atilla Sevinçli is currently the Executive Chairman at Meditera Tibbi.
Malzeme Sanayi ve Ticaret AS.
He is also the Chairman at Disera Tibbi Malzeme.
Lojistik Sanayi ve Ticaret AS and Dr. Schumacher Kimya Sanayi Ve Ticaret AS.
He completed his undergraduate degree at the University of The Aegean.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 67 095 574 ( 56,38% ) | 41 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MEDITERA TIBBI MALZEME SANAYI VE TICARET ANONIM SIRKETI | Président | 12/04/2021 |
Disera Tibbi Malzeme Lojistik Sanayi ve Ticaret AS | Président | - |
Dr. Schumacher Kimya Sanayi Ve Ticaret AS | Président | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
University of The Aegean
 University of The Aegean Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Meditera Tibbi Malzeme Sanayi ve Ticaret AS
 Meditera Tibbi Malzeme Sanayi ve Ticaret AS Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Disera Tibbi Malzeme Lojistik Sanayi ve Ticaret AS | |
Dr. Schumacher Kimya Sanayi Ve Ticaret AS |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
